文献速递甲状腺疾病

高龄老人的血清甲状腺功能、死亡率与失能:纽卡斯尔85+研究

Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study.
PubMed 文献 · J Clin Endocrinol Metab · 2016-08-23

该研究在643名85岁英国社区或机构居住老人中评估甲状腺功能与9年全因死亡、心血管死亡及失能的关系。调整年龄性别后,基线rT3和FT3与全因死亡相关(均P<.001),进一步调整混杂后仅rT3仍显著相关(P=.001)。亚临床甲状腺功能减退或亢进者9年生存率与甲状腺功能正常者无显著差异,但甲状腺功能指标可预测失能,较高的TSH水平预测更好的结局。

要点

  • 在85岁老人中,亚临床甲状腺功能减退或亢进者9年生存率与甲状腺功能正常者无显著差异。
  • 调整年龄性别后rT3和FT3与全因死亡相关(均P<.001),进一步调整后仅rT3仍显著相关(P=.001)。
  • 基线TSH和rT3分别预测女性和男性未来的失能轨迹,较高的TSH水平预测更好的结局。

核心结论

  • 85岁老人中,亚临床甲状腺功能减退和亚临床甲状腺功能亢进者的9年生存率与甲状腺功能正常者相比无显著差异。
  • 甲状腺功能检查可预测失能,较高的血清TSH水平预测更好的结局。
  • 这些数据加强了常规使用年龄特异性甲状腺功能参考范围的论据。

研究设计与样本

  • 在纽卡斯尔和北泰恩赛德(英国)参与的全科诊所注册的643名85岁老人中开展队列研究,在社区或机构住所评估健康状况和甲状腺功能,随访死亡和失能长达9年。

主要发现

  • 调整年龄和性别后,全因死亡与基线血清rT3和FT3相关(均P<.001),但与FT4或TSH无关。
  • 进一步调整潜在混杂因素后,仅rT3仍与死亡显著相关(P=.001)。
  • 基线血清TSH和rT3分别预测女性和男性未来的失能轨迹。

关键数值与推荐

  • 主要结局为全因死亡、心血管死亡和失能,依据甲状腺疾病状态和基线甲状腺激素参数(血清TSH、FT4、FT3和rT3)评估。
  • 模型调整了年龄、性别、教育、体重指数、吸烟和疾病计数。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Perturbations in thyroid function are common in older individuals but their significance in the very old is not fully understood. OBJECTIVE: This study sought to determine whether thyroid hormone status and variation of thyroid hormones within the reference range correlated with mortality and disability in a cohort of 85-year-olds. DESIGN: A cohort of 85-year-old individuals were assessed in their own homes (community or institutional care) for health status and thyroid function, and followed for mortality and disability for up to 9 years. SETTING AND PARTICIPANTS: Six hundred and forty-three 85-year-olds registered with participating general practices in Newcastle and North Tyneside, United Kingdom. MAIN OUTCOMES: All-cause mortality, cardiovascular mortality, and disability according to thyroid disease status and baseline thyroid hormone parameters (serum TSH, FT4, FT3, and rT3). Models were adjusted for age, sex, education, body mass index, smoking, and disease count. RESULTS: After adjustment for age and sex, all-cause mortality was associated with baseline serum rT3 and FT3 (both P < .001), but not FT4 or TSH. After additional adjustment for potential confounders, only rT3 remained significantly associated with mortality (P = .001). Baseline serum TSH and rT3 predicted future disability trajectories in men and women, respectively. CONCLUSIONS: Our study is reassuring that individuals age 85 y with both subclinical hypothyroidism and subclinical hyperthyroidism do not have a significantly worse survival over 9 years than their euthyroid peers. However, thyroid function tests did predict disability, with higher serum TSH levels predicting better outcomes. These data strengthen the argument for routine use of age-specific thyroid function reference ranges.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Pearce SH, Razvi S, Yadegarfar ME, et al. Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study. J Clin Endocrinol Metab. 2016. PMID: 27552542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。